On 25 June, the World Health Organization (WHO) concluded its participation in a 36-hour nuclear emergency exercise organized by the International Atomic Energy Agency (IAEA). The exercise was part of the IAEA’s Level 3 Convention Exercise (ConvEx-3), the highest and most complex level of its emergency exercises. These large-scale exercises are conducted every three to five years to test emergency preparedness and response capacities and identify areas in need of improvement. The last ConvEx-3 exercise took place in 2021 in cooperation with the United Arab Emirates. The exercise involved more than 75 countries and 10 international organizations and was based on a simulated accident at a nuclear power plant in Romania, resulting in the release of significant amounts of radioactive material. Participating countries and organizations exchanged information in real time, assessed evolving risks, coordinated communications, and decided on appropriate protective actions, including the medical response. As part of the simulation, WHO set up an Incident Management Support Team composed of experts from country, regional and headquarters offices. The WHO teams liaised with national authorities to monitor the public health impact, developed public health messages on protective actions, and provided guidance on mental health support for affected communities and emergency responders. New elements this year included the close coordination of protective measures by neighbouring countries Bulgaria and the Republic of Moldova, the deployment of international assistance missions and the additional challenge of cybersecurity threats. An expanded social media simulator was used to test crisis communication strategies. By simulating high-risk cross-border nuclear emergencies, these exercises test existing structures and technical readiness, help build trust and strengthen a coordinated global response. WHO’s ongoing work to strengthen radiation protection of the public, patients and workers worldwide includes providing Member States with evidence-based guidance, tools and technical advice on public health issues related to ionizing and non-ionizing radiation. Following the exercise, the IAEA will compile and publish a detailed review of best practices and areas for improvement. WHO will review the lessons learned and adjust processes accordingly.  

The World Health Organization (WHO) today has launched a major new initiative urging countries to raise real prices on tobacco, alcohol, and sugary drinks by at least 50% by 2035 through health taxes in a move designed to curb chronic diseases and generate critical public revenue. The “3 by 35” Initiative comes at a time when health systems are under enormous strain from rising noncommunicable diseases (NCDs), shrinking development aid and growing public debt. The consumption of tobacco, alcohol, and sugary drinks are fueling the NCD epidemic. NCDs, including heart disease, cancer, and diabetes, account for over 75% of all deaths worldwide. A recent report shows that a one-time 50% price increase on these products could prevent 50 million premature deaths over the next 50 years. “Health taxes are one of the most efficient tools we have,” said Dr Jeremy Farrar, Assistant Director-General, Health Promotion and Disease Prevention and Control, WHO. “They cut the consumption of harmful products and create revenue governments can reinvest in health care, education, and social protection. It’s time to act.” The Initiative has an ambitious but achievable goal of raising US$1 trillion over the next 10 years. Between 2012 and 2022, nearly 140 countries raised tobacco taxes, which resulted in an increase of real prices by over 50% on average, showing that large-scale change is possible. From Colombia to South Africa, governments that have introduced health taxes have seen reduced consumption and increased revenue. Yet many countries continue to provide tax incentives to unhealthy industries, including tobacco. Moreover, long-term investment agreements with industry that restrict tobacco tax increases can further undermine national health goals. WHO encourages governments to review and avoid such exemptions to support effective tobacco control and protect public health. Strong collaboration is at the heart of the “3 by 35” Initiative’s success. Led by WHO, the Initiative brings together a powerful group of global partners to help countries put health taxes into action. These organizations offer a mix of technical know-how, policy advice, and real-world experience. By working together, they aim to raise awareness about the benefits of health taxes and support efforts at the national level. Many countries have expressed interest in transitioning toward more self-reliant, domestically funded health systems and are turning to WHO for guidance. The “3 by 35” Initiative introduces key action areas to help countries, pairing proven health policies with best practices on implementation. These include direct support for country-led reforms with the following goals in mind: Cutting harmful consumption by reducing affordability; Increase or introduce excise taxes on tobacco, alcohol, and sugary drinks to raise prices and reduce consumption, cutting future health costs and preventable deaths. Raising revenue to fund health and development; Mobilize domestic public resources to fund essential health and development programmes, including universal health coverage. Building broad political support across ministries, civil society, and academia; Strengthen multisectoral alliances by engaging ministries of finance and health, parliamentarians, civil society, and researchers to design and implement effective policies. WHO is calling on countries, civil society, and development partners to support the “3 by 35” Initiative and commit to smarter, fairer taxation that protects health and accelerates progress toward the Sustainable Development Goals.

Today, Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO). This historic milestone follows nearly 70 years of commitment by the government and people of Suriname to eliminate the disease across its vast rainforests and diverse communities. “WHO congratulates Suriname on this remarkable achievement,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This certification is a powerful affirmation of the principle that everyone—regardless of nationality, background, or migration status—deserves universal access to malaria diagnosis and treatment. Suriname’s steadfast commitment to health equity serves as an inspiration to all countries striving for a malaria-free future.” With today’s announcement, a total of 46 countries and 1 territory have been certified as malaria-free by WHO, including 12 countries in the Region of the Americas. “Suriname did what was needed to eliminate malaria—detecting and treating every case quickly, investigating to prevent spread, and engaging communities,” said Dr Jarbas Barbosa, Director of the Pan American Health Organization (PAHO), WHO’s regional office for the Americas. “This certification reflects years of sustained effort, especially reaching remote areas. It means future generations can grow up free from this potentially deadly disease.” Certification of malaria elimination is granted by WHO when a country has proven, beyond reasonable doubt, that the chain of indigenous transmission has been interrupted nationwide for at least the previous three consecutive years. Dr Amar Ramadhin, Minister of Health of Suriname, stated: "Being malaria-free means that our population is no longer at risk from malaria. Furthermore, eliminating malaria will have positive effects on our healthcare sector, boost the economy, and enhance tourism. “At the same time, we recognize that maintaining this status requires ongoing vigilance. We must continue to take the necessary measures to prevent the reintroduction of malaria. We are proud that our communities are now protected, and we look forward to welcoming more visitors to our beautiful Suriname—while remaining fully committed to safeguarding these hard-won gains.” Suriname’s road to elimination Suriname’s malaria control efforts began in 1950s in the country’s densely-populated coastal areas, relying heavily on indoor spraying with the pesticide DDT and antimalarial treatment. By the 1960s, the coastal areas had become malaria-free and attention turned towards the country’s forested interior, home to diverse indigenous and tribal communities. Although indoor spraying was successful in coastal areas, its impact was limited in the country's interior due to the prevalence of traditional open-style homes that offer minimal protection against mosquitoes. In 1974 malaria control in the interior was decentralized to Medische Zending, Suriname’s primary health care service, which recruited and trained healthcare workers from the local communities to provide early diagnosis and treatment. The surge in mining activities, particularly gold mining which often involves travel between malaria-endemic areas, led to increases in malaria, reaching a peak of more than 15 000 cases in 2001, the highest transmission rates of malaria in the Americas. Since 2005, with support from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the capacity to provide diagnosis was greatly expanded with both improvements in microscopy and the use of rapid diagnostic tests, particularly among mobile groups. Artemisinin-based treatments with primaquine were introduced in Suriname and neighboring countries through PAHO-led studies under the Amazon Malaria Initiative (AMI-RAVREDA), supported by the United States. Prevention among high-risk groups was also strengthened through the distribution of insecticide-treated nets funded by the Global Fund. By 2006, malaria had drastically decreased among the indigenous populations, prompting Suriname to shift its focus to high-risk mobile populations in remote mining areas. To reach these groups—many of whom were migrants from neighboring endemic countries—the country established a network of Malaria Service Deliverers, recruited directly from the mining communities. These trained and supervised community workers provide free malaria diagnosis, treatment, and prevention services, playing a vital role in closing access gaps in hard-to-reach regions. Through ensuring universal access to diagnosis and treatment regardless of legal status, deploying an extensive network of community health workers, and implementing nationwide malaria screening, including at border crossings, Suriname successfully eliminated malaria. The last locally transmitted case of Plasmodium falciparum malaria was recorded in 2018, followed by the final Plasmodium vivax case in 2021. Sustained leadership commitment and funding The government of Suriname has shown strong commitment to malaria elimination, including through the National Malaria Elimination Taskforce, Malaria Program, Malaria Elimination Fund, and cross-border collaboration with Brazil, Guyana and French Guiana. For many years PAHO/WHO, with the support of the U.S. Government, has provided technical cooperation throughout Suriname’s anti-malaria campaign. Since 2016 Suriname also participated in the “Elimination 2025” initiative – a group of countries identified by WHO as having the potential to eliminate malaria by 2025. This success in Suriname is a demonstration that malaria elimination is possible in challenging contexts in the Amazon basin and in tropical continental countries. The country’s malaria-free certification plays a critical role in advancing PAHO's Disease Elimination Initiative which aims to eliminate more than 30 communicable diseases, including malaria, in countries of the Americas by 2030. Note to the editor WHO malaria-free certification The final decision on awarding a malaria-free certification is made by the WHO Director-General, based on a recommendation by the Technical Advisory Group on Malaria Elimination and Certification and validation from the Malaria Policy Advisory Group. For more on WHO’s malaria-free certification process, visit  this link.